Vir Biotechnology (VIR) Amortization - Intangibles (2020 - 2024)
Vir Biotechnology recorded quarterly Amortization - Intangibles of $18.8 million in Q2 2024, down 11.45% quarter-over-quarter from $21.3 million in Q1 2024, and down 18.12% year-over-year from $23.0 million in Q3 2023.
Vir Biotechnology's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $18.8 million for Q2 2024.
- In Q2 2024, Amortization - Intangibles fell 18.12% year-over-year to $18.8 million; the TTM figure through Jun 2024 stood at $82.8 million (up 18.57% YoY), while the FY2023 annual figure was $87.0 million, up 209.66% from the prior year.
- Amortization - Intangibles came in at $18.8 million for Q2 2024 at Vir Biotechnology, down from $21.3 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $23.0 million in Q2 2023 to a low of $11000.0 in Q3 2021.
- A 5-year average of $8.8 million and a median of $2.0 million in 2020 frame the typical range for Amortization - Intangibles.
- Across the five-year window, Amortization - Intangibles slumped 97.33% in 2021 and soared 84736.36% in 2022, its largest moves.
- Vir Biotechnology's Amortization - Intangibles stood at $288000.0 in 2020, then plunged by 42.01% to $167000.0 in 2021, then soared by 9583.83% to $16.2 million in 2022, then increased by 28.22% to $20.7 million in 2023, then declined by 9.11% to $18.8 million in 2024.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $18.8 million, $21.3 million, and $20.7 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 18.85 Mn |
| Mar 31, 2024 | 21.28 Mn |
| Dec 31, 2023 | 20.74 Mn |
| Sep 30, 2023 | 21.93 Mn |
| Jun 30, 2023 | 23.02 Mn |
| Mar 31, 2023 | 21.31 Mn |
| Dec 31, 2022 | 16.17 Mn |
| Sep 30, 2022 | 9.33 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 388,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 97,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Dec 31, 2020 | 288,000.00 |
| Sep 30, 2020 | 412,000.00 |
| Jun 30, 2020 | 825,000.00 |
| Mar 31, 2020 | 1.76 Mn |